A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti

Lixin Guo; Li Chen; Baocheng Chang; Liyong Yang; Yu Liu; Bo Feng

doi:10.1111/dom.13454

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti

Diabetes Obesity and Metabolism ◽

10.1111/dom.13454 ◽

2018 ◽

Vol 20 (12) ◽

pp. 2740-2747

Author(s):

Lixin Guo ◽

Li Chen ◽

Baocheng Chang ◽

Liyong Yang ◽

Yu Liu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Diabetes Patients

Download Full-text

Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study

Diabetes & Metabolism Journal ◽

10.4093/dmj.2013.37.2.117 ◽

2013 ◽

Vol 37 (2) ◽

pp. 117 ◽

Cited By ~ 5

Author(s):

Kee-Ho Song ◽

Jung Min Kim ◽

Jung-Hyun Noh ◽

Yongsoo Park ◽

Hyun-Shik Son ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Antidiabetic Therapy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)

Diabetes & Metabolism Journal ◽

10.4093/dmj.2013.37.3.212 ◽

2013 ◽

Vol 37 (3) ◽

pp. 212

Author(s):

Byung-Wan Lee

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Antidiabetic Therapy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: An 18-week, randomized, open-label study

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.09.001 ◽

2005 ◽

Vol 27 (9) ◽

pp. 1432-1443 ◽

Cited By ~ 15

Author(s):

Itamar Raz ◽

Stephen Stranks ◽

Robert Filipczak ◽

Pankaj Joshi ◽

Benedikte Lertoft ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Safety and efficacy of biphasic insulin aspart 30 in type 2 diabetes patients switched from either biphasic or basal human insulin: results from the Gulf cohort of the A1chieve study

International Journal of Clinical Practice ◽

10.1111/ijcp.12391 ◽

2014 ◽

Vol 68 (7) ◽

pp. 850-856 ◽

Cited By ~ 3

Author(s):

A. Almansari ◽

S. Khader ◽

A. Kharawagh ◽

W. AbdelFattah ◽

T. Badawy

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Safety And Efficacy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Diabetes Patients

Download Full-text

Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Filipino cohort of the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(13)70008-1 ◽

2013 ◽

Vol 100 ◽

pp. S35-S40 ◽

Cited By ~ 3

Author(s):

Mary Anne Lim-Abrahan ◽

Susan Yu-Gan ◽

Anand B. Jain ◽

Leorino M. Sobrepena ◽

Veronica A. Racho

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Diabetes Patients

Download Full-text

Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

Current Medical Research and Opinion ◽

10.1185/030079907x253636 ◽

2007 ◽

Vol 23 (12) ◽

pp. 3209-3214 ◽

Cited By ~ 29

Author(s):

M. Shestakova ◽

S. K. Sharma ◽

M. Almustafa ◽

K. W. Min ◽

N. Ayad ◽

...

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Diabetes Patients

Download Full-text

Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Indonesian cohort of the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(13)70009-3 ◽

2013 ◽

Vol 100 ◽

pp. S41-S46 ◽

Cited By ~ 4

Author(s):

Pradana Soewondo ◽

Dharma Lindarto ◽

Sony Wibisono ◽

Olly Renaldi ◽

Tjokorda Gde Dalem-Pemayun

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Clinical Safety ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Diabetes Patients

Download Full-text

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

Current Medical Research and Opinion ◽

10.1185/03007990903354674 ◽

2009 ◽

Vol 25 (12) ◽

pp. 2887-2894 ◽

Cited By ~ 56

Author(s):

Krzysztof Strojek ◽

Wan M.W. Bebakar ◽

Duma T. Khutsoane ◽

Milica Pesic ◽

Alena Šmahelová ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Oral Drugs ◽

Open Label ◽

Once Daily ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus

Clinical Therapeutics ◽

10.1016/s0149-2918(04)90055-0 ◽

2004 ◽

Vol 26 (4) ◽

pp. 531-540 ◽

Cited By ~ 67

Author(s):

L NISKANEN

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Lispro ◽

Insulin Aspart ◽

Open Label ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 diabe

Journal of Diabetes Investigation ◽

10.1111/j.2040-1124.2010.00015.x ◽

2010 ◽

Vol 1 (3) ◽

pp. 103-110 ◽

Cited By ~ 4

Author(s):

Takashi Kadowaki ◽

Tomoyuki Nishida ◽

Kohei Kaku

Keyword(s):

Insulin Aspart ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Trial ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Parallel Group

Download Full-text